Winter Park, Florida–(Newsfile Corp. – February 16, 2026) – Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative therapeutic solutions, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted its second clinical study for Institutional Review Board (IRB) review. This pivotal study will evaluate the efficacy of AdiaVita, Adia Med’s proprietary umbilical cord blood-derived stem cell and exosome product, in alleviating lower back pain through
Adia Nutrition Announces Subsidiary Adia Med’s Submission of Second Clinical Study for IRB Review Targeting Lower Back Pain with AdiaVita
Latest from Blog
Nutrition nonprofit holds roundtable discussion in Fitzgerald
While their focus may be on providing aid around the globe, MANA Nutrition is doing what they can to keep American farmers in mind. Post Views: 2
ROFI Drives New Approach to Crop Nutrition
With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
STAT+: A new attack on AMA’s billing codes
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Brain
Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now MedNews
TUESDAY, May 5, 2026 U.S. Supreme Court Justice Samuel Alito Jr. issued an order Monday that allows patients to continue accessing abortion pill, mifepristone, Post Views: 0
Tippecanoe schools hire new nutrition leader
Alison Jordan has been hired as the new nutrition services director for Tippecanoe School Corporation, overseeing meals for 20 schools. Post Views: 2